Data from the U.S. indicate that between 5 to 10 percent of mothers consume psychostimulants (such as amphetamine, cocaine or methamphetamine) during pregnancy. Apart from the negative impacts on the developing brain, many ...
Nov 21, 2019
0
1
Mining the rich uncharted territory of the genome or genetic material of a cancer cell has yielded gold for Princess Margaret scientists: new protein targets for drug development against prostate cancer.
Nov 15, 2019
0
51
Immunologists at St. Jude Children's Research Hospital have discovered key biological switches that control regulatory T cells—specialized white blood cells that keep the immune system in check. A paper detailing this work ...
Oct 24, 2019
0
320
A new approach to treat advanced breast cancer shuts down the growth of cells that become resistant to standard hormone therapy, according to Duke Cancer Institute animal studies.
Oct 23, 2019
0
172
Scientists have shown exactly how mutations in two different genes coordinate to drive the development of malignant lung tumors, according to a new report in the open-access journal eLife.
Aug 27, 2019
0
6
Men should be included in clinical trials of new breast cancer treatments, the U.S. Food and Drug Administration says.
Aug 27, 2019
0
28
With the help of new technology, the researchers of the University of Turku in Finland have gained more detailed information on the diversity of the human lymphatic system than before. The research results can help to understand ...
Aug 13, 2019
0
1
The Ivy Brain Tumor Center at the Barrow Neurological Institute, has released the results of its recent Phase 0 clinical trial of the breast cancer drug ribociclib (Kisqali) for the treatment of recurrent glioblastoma. The ...
Jul 25, 2019
0
8
A bone cancer known as osteosarcoma is genetically similar in dogs and human children, according to the results of a study published today by Tufts University and the Translational Genomics Research Institute (TGen), an affiliate ...
Jul 19, 2019
0
4
(HealthDay)—The first personalized treatment for patients with metastatic bladder cancer and susceptible fibroblast growth factor receptor (FGFR) genetic alterations was granted accelerated approval by the U.S. Food and ...
Apr 15, 2019
0
1
